Barry A. Bunin
Impact in
-
- Computational Drug Discovery Methods
- Organic Chemistry top 5%
- Click Chemistry and Applications
Papers in
-
- Computational Drug Discovery Methods 21
-
- Chemical Synthesis and Analysis 10
- Genetics, Bioinformatics, and Biomedical Research 5
- Bioinformatics and Genomic Networks 4
- Co-authors
- Jonathan A. Ellman (3 shared papers)Sean Ekins (18 shared papers)Matthew J. Plunkett (3 shared papers)Moses M. Hohman (4 shared papers)Peter John Smith (1 shared paper)Kelly Chibale (1 shared paper)Joel S. Freundlich (3 shared papers)Robert C. Reynolds (2 shared papers)
- Journals
- Drug Discovery Today (4 papers)Pharmaceutical Research (4 papers)Journal of the American Chemical Society (2 papers)Molecular BioSystems (2 papers)Annual reports in medicinal chemistry (1 paper)
- Partner nations
- United StatesAustraliaSouth Africa
In The Last Decade
Barry A. Bunin
34 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 105
- Computational Theory and Mathematics 499
- Organic Chemistry 471
- Infectious Diseases 256
- Molecular Biology 894
- Pharmacology 85
Countries citing papers authored by Barry A. Bunin
This map shows the geographic impact of Barry A. Bunin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry A. Bunin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry A. Bunin more than expected).
Fields of papers citing papers by Barry A. Bunin
This network shows the impact of papers produced by Barry A. Bunin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry A. Bunin. The network helps show where Barry A. Bunin may publish in the future.
Co-authors
The 25 scholars most cited alongside Barry A. Bunin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 366 | |
| 2 | 1994 | 227 | |
| 3 | 2009 | 120 | |
| 4 | 2013 | 90 | |
| 5 | 2010 | 80 | |
| 6 | 2015 | 80 | |
| 7 | 2010 | 75 | |
| 8 | 2010 | 64 | |
| 9 | 2013 | 51 | |
| 10 | 2013 | 35 | |
| 11 | 2012 | 27 | |
| 12 | 2013 | 27 | |
| 13 | 2013 | 24 | |
| 14 | 1996 | 21 | |
| 15 | 1999 | 21 | |
| 16 | 1996 | 20 | |
| 17 | 2015 | 19 | |
| 18 | 2014 | 18 | |
| 19 | 2010 | 16 | |
| 20 | 2014 | 15 |
About Barry A. Bunin
Barry A. Bunin is a scholar working on Computational Theory and Mathematics, Molecular Biology, Pharmacology, Organic Chemistry and Infectious Diseases, having authored 36 papers that have together received 1.5k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (21 papers), Chemical Synthesis and Analysis (10 papers), Tuberculosis Research and Epidemiology (7 papers), Genetics, Bioinformatics, and Biomedical Research (5 papers), Click Chemistry and Applications (5 papers), Pharmacogenetics and Drug Metabolism (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Bioinformatics and Genomic Networks (4 papers). The work is most often cited by research in Computational Theory and Mathematics (499 citations), Organic Chemistry (471 citations), Infectious Diseases (256 citations), Molecular Biology (894 citations) and Pharmacology (85 citations). Barry A. Bunin has collaborated with scholars based in United States, Australia and South Africa. Frequent co-authors include Jonathan A. Ellman, Sean Ekins, Matthew J. Plunkett, Moses M. Hohman, Peter John Smith, Kelly Chibale, Joel S. Freundlich, Robert C. Reynolds, Eric Gifford and Nadia K. Litterman. Their work appears in journals such as Drug Discovery Today, Pharmaceutical Research, Journal of the American Chemical Society, Molecular BioSystems and Annual reports in medicinal chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.